Clinical Scorecard: Tumor-Induced Maintenance of CD8+ T Cell Exhaustion and Its Impact on Cancer Immunotherapy

At a Glance

Key Highlights

• CD8+ T cell exhaustion is a regulated differentiation program induced by chronic antigen stimulation.
• Exhausted T cells display sustained expression of multiple inhibitory receptors.
• Exhaustion is characterized by a hierarchical loss of effector functions.
• Transcription factors like NFAT and TOX play critical roles in establishing and maintaining exhaustion.
• Checkpoint inhibition can temporarily restore function but does not fully reprogram exhausted T cells.

Guideline-Based Recommendations

Diagnosis

• Identify CD8+ T cell exhaustion through assessment of inhibitory receptor expression and functional assays.

Management

• Consider combinatorial approaches targeting inhibitory receptors, metabolic resilience, and epigenetic architecture.

Monitoring & Follow-up

• Monitor T cell functionality and exhaustion markers during immunotherapy.

Risks

• Persistent exhaustion may limit the effectiveness of immunotherapy.

Patient & Prescribing Data

Patients with tumors exhibiting CD8+ T cell exhaustion.

Effective immunotherapy may require strategies that address both inhibitory signaling and metabolic stress.

Clinical Best Practices

• Utilize immune checkpoint inhibitors as part of a broader strategy to combat T cell exhaustion.
• Evaluate the tumor microenvironment for factors contributing to T cell dysfunction.
• Incorporate assessments of epigenetic changes in T cells to inform treatment decisions.

Related Resources & Content

• Source Article